Mannkind (MNKD) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.51% |
| Dec 31, 2025 | 26.08% |
| Sep 30, 2025 | 26.28% |
| Jun 30, 2025 | 25.94% |
| Mar 31, 2025 | 25.87% |
| Dec 31, 2024 | 26.10% |
| Sep 30, 2024 | 25.76% |
| Jun 30, 2024 | 25.69% |
| Mar 31, 2024 | 26.56% |
| Dec 31, 2023 | 26.89% |
| Sep 30, 2023 | 25.69% |
| Jun 30, 2023 | 21.70% |
| Mar 31, 2023 | 15.67% |
| Dec 31, 2022 | 10.88% |
| Sep 30, 2022 | 8.51% |
| Jun 30, 2022 | 6.31% |
| Mar 31, 2022 | 7.79% |
| Dec 31, 2021 | 4.82% |
| Sep 30, 2021 | -8.01% |
| Jun 30, 2021 | -9.91% |
| Mar 31, 2021 | -11.21% |
| Dec 31, 2020 | -11.90% |
| Sep 30, 2020 | -33.06% |
| Jun 30, 2020 | -32.99% |
| Mar 31, 2020 | -32.80% |
| Dec 31, 2019 | -32.57% |
| Sep 30, 2019 | -32.31% |
| Jun 30, 2019 | -31.77% |
| Mar 31, 2019 | -31.94% |
| Dec 31, 2018 | -32.04% |
| Sep 30, 2018 | -32.12% |
| Jun 30, 2018 | -32.04% |
| Mar 31, 2018 | -32.01% |
| Dec 31, 2017 | -31.91% |
| Sep 30, 2017 | -31.88% |
| Jun 30, 2017 | -31.79% |
| Mar 31, 2017 | -31.65% |
| Dec 31, 2016 | -31.59% |
| Sep 30, 2016 | -24.93% |
| Jun 30, 2016 | -25.04% |
| Dec 31, 2015 | -24.77% |